Nurix Therapeutics, Inc. financial data

Symbol
NRIX on Nasdaq
Industry
Pharmaceutical Preparations
Location
1700 Owens Street, Suite 205, San Francisco, CA
State of incorporation
DE
Fiscal year end
November 30
Former names
Nurix, Inc. (to 9/18/2015)
Latest financial report
10-Q - Q3 2024 - Oct 11, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 425 % -1.69%
Debt-to-equity 51.6 % +47.7%
Return On Equity -63.4 % -14.2%
Return On Assets -41.8 % -1.63%
Operating Margin -195 % +55.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 70.8M shares +46%
Common Stock, Shares, Outstanding 67.1M shares +38.3%
Entity Public Float 471M USD +6.16%
Common Stock, Value, Issued 67K USD +36.7%
Weighted Average Number of Shares Outstanding, Basic 72.8M shares +33.8%
Weighted Average Number of Shares Outstanding, Diluted 72.8M shares +33.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 80.9M USD +94%
Revenue from Contract with Customer, Excluding Assessed Tax 12.6M USD -31.8%
Research and Development Expense 204M USD +10%
General and Administrative Expense 46M USD +10.9%
Operating Income (Loss) -194M USD -22.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -177M USD -18.8%
Income Tax Expense (Benefit) 82K USD
Net Income (Loss) Attributable to Parent -177M USD -19%
Earnings Per Share, Basic -2.91 USD/shares -6.59%
Earnings Per Share, Diluted -2.91 USD/shares -6.59%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 99M USD +134%
Marketable Securities, Current 217M USD -27.1%
Cash, Cash Equivalents, and Short-term Investments 448M USD +73.1%
Accounts Receivable, after Allowance for Credit Loss, Current 2M USD
Assets, Current 456M USD +70.2%
Property, Plant and Equipment, Net 17.1M USD +2.94%
Operating Lease, Right-of-Use Asset 27.1M USD +200%
Other Assets, Noncurrent 3.03M USD -21.3%
Assets 514M USD +66.6%
Accounts Payable, Current 3.92M USD +79.2%
Employee-related Liabilities, Current 11.7M USD +1.48%
Contract with Customer, Liability, Current 48M USD +49.8%
Liabilities, Current 86.3M USD +40.3%
Contract with Customer, Liability, Noncurrent 29.9M USD +191%
Operating Lease, Liability, Noncurrent 20.6M USD +679%
Liabilities 137M USD +83.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax 344K USD
Retained Earnings (Accumulated Deficit) -680M USD -35.2%
Stockholders' Equity Attributable to Parent 377M USD +61.2%
Liabilities and Equity 514M USD +66.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -42M USD +13.4%
Net Cash Provided by (Used in) Financing Activities 1.62M USD +9.66%
Net Cash Provided by (Used in) Investing Activities 35.5M USD +121%
Common Stock, Shares Authorized 500M shares 0%
Common Stock, Shares, Issued 67.1M shares +38.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -4.81M USD +84.4%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 99.9M USD +131%
Deferred Tax Assets, Valuation Allowance 194M USD +40%
Deferred Tax Assets, Gross 203M USD +43.1%
Operating Lease, Liability 30.6M USD +156%
Payments to Acquire Property, Plant, and Equipment 2.88M USD +26.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -175M USD -20%
Lessee, Operating Lease, Liability, to be Paid 42.4M USD -9.13%
Property, Plant and Equipment, Gross 49.2M USD +18.1%
Operating Lease, Liability, Current 6.55M USD +22.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.57M USD -38.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 7.65M USD +9.54%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure +101%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 11.8M USD +2652%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.91M USD -32.7%
Deferred Tax Assets, Operating Loss Carryforwards 92.1M USD +9.97%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 15.5M USD +51.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.99M USD +12.1%
Operating Lease, Payments 1.92M USD +38.2%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 8.94M USD +171%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%